1. Home
  2. RXRX vs KYN Comparison

RXRX vs KYN Comparison

Compare RXRX & KYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RXRX
  • KYN
  • Stock Information
  • Founded
  • RXRX 2013
  • KYN 2004
  • Country
  • RXRX United States
  • KYN United States
  • Employees
  • RXRX 500
  • KYN N/A
  • Industry
  • RXRX Biotechnology: Pharmaceutical Preparations
  • KYN Finance/Investors Services
  • Sector
  • RXRX Health Care
  • KYN Finance
  • Exchange
  • RXRX Nasdaq
  • KYN Nasdaq
  • Market Cap
  • RXRX 2.0B
  • KYN 2.0B
  • IPO Year
  • RXRX 2021
  • KYN N/A
  • Fundamental
  • Price
  • RXRX $6.95
  • KYN $12.57
  • Analyst Decision
  • RXRX Buy
  • KYN
  • Analyst Count
  • RXRX 6
  • KYN 0
  • Target Price
  • RXRX $9.40
  • KYN N/A
  • AVG Volume (30 Days)
  • RXRX 4.1M
  • KYN 561.5K
  • Earning Date
  • RXRX 11-06-2024
  • KYN 01-01-0001
  • Dividend Yield
  • RXRX N/A
  • KYN 8.99%
  • EPS Growth
  • RXRX N/A
  • KYN N/A
  • EPS
  • RXRX N/A
  • KYN 0.71
  • Revenue
  • RXRX $65,184,000.00
  • KYN N/A
  • Revenue This Year
  • RXRX $57.90
  • KYN N/A
  • Revenue Next Year
  • RXRX $35.23
  • KYN N/A
  • P/E Ratio
  • RXRX N/A
  • KYN $13.79
  • Revenue Growth
  • RXRX 37.64
  • KYN N/A
  • 52 Week Low
  • RXRX $5.04
  • KYN $7.84
  • 52 Week High
  • RXRX $15.74
  • KYN $9.88
  • Technical
  • Relative Strength Index (RSI)
  • RXRX 58.41
  • KYN 76.17
  • Support Level
  • RXRX $6.22
  • KYN $11.48
  • Resistance Level
  • RXRX $6.90
  • KYN $11.84
  • Average True Range (ATR)
  • RXRX 0.32
  • KYN 0.20
  • MACD
  • RXRX 0.05
  • KYN 0.06
  • Stochastic Oscillator
  • RXRX 100.00
  • KYN 98.28

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

About KYN Kayne Anderson Energy Infrastructure Fund Inc.

Kayne Anderson Energy Infrastructure Fund, Inc is a non-diversified, closed-end fund. Its investment objective is to provide a high after-tax total return with an emphasis on making cash distributions to the stockholder. The company seeks to achieve its objectives by investing a majority of its total assets in the securities of Energy Infrastructure companies.

Share on Social Networks: